A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

This study has been completed.

Study NCT00513656 Information provided by Mundipharma Research GmbH & Co KG

First Received: July 27, 2007 Last Updated: August 2, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	June 2010
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)

No publications provided by Mundipharma Research GmbH & Co KG

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliat Med. 2012 Jan;26(1):50-60. Epub 2011 Sep 21.